Gemcitabine and vinorelbine combinations in the treatment of non-small cell lung cancer

Seminars in Oncology

Volumn 26, Issue 5 SUPPL. 16, 1999, Pages 67-72

  Herbst, R S ^a   Lilenbaum, R ^a   Eckardt, ^a   Green, ^a   Gralla, ^a   Langer, ^a   Eastman, ^a   Socinski, ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; NAVELBINE;

ARTICLE; BLOOD TOXICITY; CANCER SURVIVAL; CLINICAL TRIAL; CONSTIPATION; DISEASE COURSE; DRUG TOLERABILITY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; NEUROPATHY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHLEBITIS; PRIORITY JOURNAL; RASH; SURVIVAL RATE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CLINICAL TRIALS; DEOXYCYTIDINE; HUMANS; LUNG NEOPLASMS; SURVIVAL ANALYSIS; VINBLASTINE;

EID: 0032740755     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)